Abstracts for poster presentation

IPIC2017 Submit your abstract

Approved abstracts for poster presentation

IPIC2017 welcomed the submission of abstracts for original contributions to the field of clinical care of Primary Immunodeficiencies (PIDs) until July 17, 2017.

174 were approved for poster presentation and the 3 best posters have now been identified!
A full list of approved abstracts can be checked below.

List of approved abstracts

1st Place
MERIEM BEN-ALI – HOMOZYGOUS TCF3 MUTATION IS ASSOCIATED WITH SEVERE HYPOGAMMAGLOBULINEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA

2nd Place
NICHOLAS BRODSZKI
– ALONE OR ADD-ON? INHALING NEBULISED IMMUNOGLOBULINS: 18 MONTHS OF REAL LIFE EXPERIENCE

3rd Place
NGUYEN LIEN ANH PHAN
– CASE SERIES REPORT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PRIMARY IMMUNODEFICIENCIES: A SINGLE-INSTITUTION STUDY AT THE CHILDREN’S HOSPITAL 1, HO CHI MINH, VIETNAM


Following posters ordered by submission date:
(1st authors’s name-Abstract title)

ABDALLAH S. – IN SILICO ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPS) IN HUMAN RAG 1&RAG2 GENES OF SEVERE COMBINED IMMUNODEFICIENCY FROM FUNCTIONAL ANALYSIS TO POLYMORPHISMS IN MICRORNA
ABDELKADER S. – INTERLEUKIN-7 RECEPTOR ALPHA DEFICIENCY: ANALYSIS OF CLINICAL, IMMUNOLOGICAL AND MOLECULAR FEATURES IN EGYPTIAN SCID PATIENTS
ADELI M. – TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS INCREASE RISK OF MYELOSUPPRESSION IN PRIMARY IMMUNE DEFICIENCY DISEASE PATIENTS: RETROSPECTIVE THREE GROUPS COMPARISON STUDY
ALAO M. – PRIMARY IMMUNODEFICIENCIES AND CHROMOSOMAL DISORDERS: EXPERIENCE OF A MEDICAL GENETIC SERVICE IN COTONOU, BENIN.
ALDAVE J. – GIVE BOTH HANDS TO YOUR IMMUNOCYTES TO FIND 100 HIDDEN PATIENTS WITH PRIMARY IMMUNODEFICIENCY!
ALLENDE L. – APPROACH FOR DIAGNOSIS IN PRIMARY IMMUNODEFICIENCY DISEASES: FROM T-CELL-RECEPTOR-EXCISION CIRCLES (TRECS) TO NEXT GENERATION SEQUENCING
ALRUMAYYAN N. – THE IMPACT OF BCGITIS CAUSED BY BCG VACCINE ON THE OUTCOME OF SEVERE COMBINED IMMUNODEFICIENCY PATIENTS: A SINGLE-CENTER EXPERIENCE
ASGARDOON M. – PRIMARY IMMUNODEFICIENCY DISORDERS: AWARENESS SURVEY OF PHYSICIANS IN IRAN
AYAN B. – A GIRL WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
BEN YOUSSIF H. – AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) : A PRIMARY IMMUNODEFICENCY
BENHSAIEN I. – MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II DEFICIENCY: DIAGNOSIS CIRCUMSTANCE
BERGEMANN R. – ADA-SCID: THE BURDEN AND IMPACT ON THE PATIENT, CAREGIVER AND FAMILY. A QUALITATIVE RESEARCH IN USA, ITALY, FRANCE AND UK
BERNER T. – TREATMENT SATISFACTION DURING PIVOTAL CLINICAL TRIALS WITH THE NEW SUBCUTANEOUS IMMUNOGLOBULIN 20% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES PREVIOUSLY TREATED WITH INTRAVEOUS IMMUNOGLOBULIN
BERNER T. – TREATMENT PREFERENCE ON THE NEW SUBCUTANEOUS IMMUNOGLOBULIN 20% TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES IN EUROPE
BERNER T. – OVERALL AND PEDIATRIC PATIENT PREFERENCES FOR RECOMBINANT HUMAN HYALURONIDASE (RHUPH20)-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G (FSCIG) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
BIENVENU B. – RAPID PUSH INFUSION IS A WELL-TOLERATED, COST-EFFECTIVE ADDITIONAL METHOD FOR SUBCUTANEOUS SELF-INJECTIONS OF GAMMANORM®: A RANDOMIZED CROSS-OVER TRIAL IN ADULT PID PATIENTS
BONDARENKO A. – PID REGISTRY IN UKRAINE
BORTE M. – FEW ADRS WHEN SWITCHING PRIMARY IMMUNE DEFICIENCY PATIENTS TO THE NEW IVIG PANZYGA®
BOYARCHUK O. – INDIVIDUAL APPROACH TO PATIENTS WITH 22Q11.2 DELETION SYNDROME
CAMCIOGLU Y. – AN OBSERVATIONAL STUDY ABOUT SWITCHING FROM IVIG TO SCIG ?
CAMCIOGLU Y. – OUTCOME OF ASPERGILLUS INFECTIONS IN PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE
CARRABBA M. – ANTI-IGA ANTIBODIES IN PRIMARY ANTIBODY DEFICIENCIES UNDER REPLACEMENT THERAPY. WHAT DOES THERE MEAN?
CARRABBA M. – CHRONIC GASTROINTESTINAL INVOLVEMENT IN COMMON VARIABLE IMMUNODEFICIENCY DISEASES (CVID)
CARRABBA M. – MYVIP: A WEB-BASED TOOL FOR THE THERAPEUTIC ALLIANCE BETWEEN ITALIAN PIDS PATIENTS AND DOCTORS
CESONI MARCELLI A. – ADIPONECTIN EXPRESSION AND EFFECT OF IMMUNOGLOBULIN THERAPY IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY
COOPMANS E. – ANTERIOR PITUITARY DYSFUNCTION IN PATIENTS WITH PRIMARY ANTIBODY DEFICIENCIES
CRISAN R. – ANAPHYLACTIC SHOCK- INDUCED BY INTRAVENOUS IMMUNOGLOBULIN THERAPY IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS
CRONE J. – ETHICS OF COMPENSATED PLASMA DONATION
DAVTYAN H. – ASSOCIATION BETWEEN PLCE1 POLYMORPHISMS AND BREAST CANCER RISK IN ARMENIAN POPULATION
DERYABINA S. – RETROSPECTIVE GENETIC TESTING OF NEWBORNS FOR SCID AND AGAMMAGLOBULINEMIA IN SVERDLOVSK REGION
DOBRICAN C. – CELIAC DISEASE IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY
DRABWELL J – BURDEN OF IMMUNOGLOBULIN TREATMENT IN PRIMARY IMMUNODEFICIENCY DISORDERS: FINDINGS FROM AN INTERNATIONAL PATIENT SURVEY
DUFF C. – INITIATION OF 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY NAÏVE TO IG THERAPY
EBZEEVA I. – PENTAGLOBIN USE EXPERIENCE AMONG PATIENTS WITH GENERAL VARIABLE IMMUNODEFICIENCY.
EBZEEVA I. – HEREDITARY ANGIOEDEMA TYPE I MONITORING EXPERIENCE AMONG ADULTS.
ELLERBROEK P. – SENEQA: STUDY ON THE UTILISATION OF HYQVIA (10% NORMAL IMMUNOGLOBULIN AND RECOMBINANT HUMAN HYALURONIDASE) IN ELDERLY PATIENTS
ERIC Z. – AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE III: A CASE REPORT
ERRAMI A. – MUTATION OF IL12RB1 REVEALED BY BCGITIS: ABOUT 4 CASES
FIRTINA S. – MOLECULAR DIAGNOSIS OF SCID PATIENTS BY A CUSTOM DESIGNED TARGETED NEXT GENERATION SEQUENCING PANEL
FOMICHEV V. – A CLINICAL CASE OF SEVERE COMBINED IMMUNODEFICIENCY (OMENN SYNDROME): DIFFICULTIES IN THE INTERPRETATION OF SKIN LESIONS
FRANÇA T.T. – IMMATURE CIRCULATING NEUTROPHILS IN CD40L-DEFICIENT PATIENTS HAVE IMPAIRED NETS FORMATION
FRANCIS D. – AN ASSESSMENT OF DENTAL CARIES AND PERIODONTAL DISEASE STATUS IN PATIENTS WITH ULCERATIVE COLITIS – AN INFLAMMATORY BOWEL DISEASE.
FUST R – SUCCESSFUL PATIENT-DRIVEN SELF-ADMINISTRATIONS OF FACILITATED SUBCUTANEOUS IMMUNE GLOBULIN (FSCIG) TREATMENTS WITH MECHANICAL SYRINGE INFUSION SYSTEM AND A NOVEL ADJUSTABLE FLOW RATE CONTROLLER (AFRC)
FUST R – DECREASING BURDEN OF TREATMENT” – PATIENT-REPORTED EXPERIENCES OF SUBCUTANEOUS FACILITATED IMMUNOGLOBULIN TREATMENT (FSCIG) IN ADULTS WITH PRIMARY AND SECONDARY IMMUNODEFICIENCY
FUST R. – INCIDENCE OF DRUG LEAKAGE WHEN GIVING SUBCUTANEOUS IMMUNE GLOBULIN (SCIG) AND FACILITATED SUBCUTANEOUS IMMUNE GLOBULIN (FSCIG) TREATMENTS – IS IT MORE FREQUENT THAN EXPECTED?
FUST R. – HOW TO SELECT OPTIMAL NEEDLE LENGTH FOR SUBCUTANEOUS IMMUNE GLOBULIN INFUSIONS (SCIG)
GABBOUJ F.Z. – THE HYPER IG-E SYNDROME (HIES)
GONZALEZ-GRANADO L. – CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY (CMMRD) & HYPOGAMMAGLOBULINEMIA: A TWO WAY ROAD FOR PID DIAGNOSIS
GRYWALSKA E. – RECOMBINANT HUMAN HYALURONIDASE FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN TREATMENT IN ADULT PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: A POLISH SINGLE-CENTER EXPERIENCE
GULERIA S. – A CHILD WITH IDIOPATHIC CD4 LYMPHOCYTOPENIA AND RECURRENT INFECTIONS
GULERIA S. – CHRONIC GRANULOMATOUS DISEASE PROFILE IN CHILDREN FROM A TERTIARY CARE INSTITUTION IN NORTH INDIA
GULERIA S. – CHRONIC GRANULOMATOUS DISEASE PROFILE IN CHILDREN FROM A TERTIARY CARE INSTITUTION IN NORTH INDIA
GUPTA S. – THE ONBOARDING EXPERIENCE AND TOLERABILITY OF THE NEW 20% HUMAN IMMUNE GLOBULIN FOR SUBCUTANEOUS ADMINISTRATION IN NORTH AMERICA
HAMADA A. – EFFECT OF CHRONIC PHYSICAL STRESS ON IMMUNE SYSTEM
HATIRNAZ NG O. – TREC/KREC ANALYSIS AND THEIR CLINICAL CORRELATION IN SEVERE COMBINED IMMUNE DEFICIENCY
HELMER E. – SELETALISIB, A PI3K DELTA INHIBITOR, DEMONSTRATES BIOLOGICAL AND CLINICAL EFFECT IN ACTIVATED PI3K DELTA SYNDROME PATIENTS (APDS): RESULTS FROM A PROOF OF CONCEPT STUDY
HEROPOLITANSKA-PLISZKA E. – CUTANEOUS AND SOLID ORGANS GRANULOMAS IN PATIENTS WITH NIJMEGEN BREAKAGE SYNDROME (NBS) – DIAGNOSTIC AND TREATMENT CHALLENGE
HILFANOVA A. – THE ROLE OF PATIENT ORGANIZATION IN INCREASING TREATMENT COMPLIANCE IN PATIENTS WITH PID
ISLAM M. – PRIMARY IMMUNODEFICIENCY DISORDERS IN BANGLADESH: AN EXPERIENCE AT A TERTIARY HOSPITAL IN BANGLADESH.
ISMAIL I.H. – SEVERE COMBINED IMMUNODEFICIENCY: MALAYSIA’S FIRST SUCCESSFUL HLA-IDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN A 1½-MONTH-OLD CHILD
ISMAIL I.H. – HYPER IGE SYNDROME: OFTEN A MISSED DIAGNOSIS IN COUNTRIES WITH LIMITED FACILITY FOR MOLECULAR ANALYSIS
JEDDANE L. – LABORATORY DIAGNOSIS OF PRIMARY IMMUNODEFICIENCIES: WHICH TEST, WHICH METHOD?
JEDDANE L. – PRIMARY IMMUNODEFICIENCIES ON SMARTPHONE: A NEW APP FOR PID CLASSIFICATION
JOHNS D. – ORAL MANIFESTATIONS OF TWO GENETIC VARIANTS(STAT3AND DOCK8) OF HYPERIMMUNOGLOBULIN-E SYNDROME (HIES)
KANDASAMY K. – HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR IL 10 RECEPTOR DEFICIENCY IN TWO CHILDREN WITH EARLY INFLAMMATORY BOWEL DISEASE: THE JOURNEY TO CURE IN AN UNRECOGNIZED AND YET LIFE-THREATENING CONDITION
KARAKOC-AYDINER E – RAPID SCIG INFUSION IN PRIMARY IMMUNE DEFICIENCY PATIENTS; MARMARA EXPERIENCE
KARAKOC-AYDINER E – ADVERSE REACTIONS TO IVIG IN PRIMARY IMMUNE DEFICIENCY PATIENTS; MARMARA EXPERIENCE
KARIM A. – STAT3 RELATED HYPER-IGE SYNDROME IN A BOY WITH HIGH EOSINOPHILIA AND A NONSENSE MUTATION IN THE LINKER DOMAIN
KATPATTIL S. – DISEASE BURDEN FOR PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES – A COMPARATIVE STUDY
KECHOUT N. – LEUKOCYTE ADHESION DEFICIENCY TYPE I IN ALGERIAN PATIENTS
KHAZAEI H. – CORRELATION BETWEEN SERUM AMOUNTS OF TOTAL IGE, C3 AND C4 LEVELS IN PATIENTS SUFFERED FROM IGA DEFICIENCY WITH AND WITHOUT ALLERGIC RHINITIS SYMPTOMS
KILIC GULTEKIN S. – ASSESSMENT OF BONE MINERALIZATION IN SCN PATIENTS WITH HAX1 OR ELANE MUTATIONS
KIM J.H. – IGG3 SUBCLASS DEFICIENCY AS A PREDICTIVE MARKER OF MORTALITY IN PATIENTS ADMITTED TO ICU
KÖKER M. – CD11B EXPRESSION IN CGD PATIENTS AND ITS USE IN X-CGD CARRIER DETECTION.
KUMAR A. – HEALTH-RELATED QUALITY OF LIFE OF CHILDREN WITH PRIMARY IMMUNODEFICIENCY DISEASE
KUMAR N. – ROLE OF B-CELLS FOR THE INITIATION OF INSULITIS AND SIALITIS IN NONOBESE DIABETIC MICE
KUMAR P. – PREVALENCE AND CLINICAL SIGNIFICANCE OF DIABETES MELLITUS IN HUMAN IMMUNODEFICENCY VIRUS POSITIVE PATIENTS IN NEW DELHI, INDIA
KUMRAH R. – LATE PRESENTATION OF CHRONIC GRANULOMATOUS DISEASE
LAHMAR O. – ASSOCIATION BETWEEN VITAMIN D METABOLISM GENE POLYMORPHISMS AND RISK OF ADULTS ‘ASTHMA
LAM M. – CHEDIAK-HIGASHI SYNDROME AND GRISCELLI SYNDROME TYPE2: TWO CASES WITH PRIMARY IMMUNODEFICIENCY ASSOCIATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AT THE CHILDREN HOSPITAL 1 IN HO CHI MINH CITY
LAVRINENKO V. – DONOR CELL ENGRAFTMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
LEONARDI L. – AUTOIMMUNITY IN IGA DEFICIENCY PATIENTS: ROLE OF T REGS
LEWANDOWICZ-USZYNSKA A. – 22Q11.2 DELETION SYNDROME THE CAUSE OF PHYSICAL DEVELOPMENT DISORDERS – CASE REPORT
LEWANDOWICZ-USZYNSKA A. – DO CHILDREN WITH RECURRENT INFECTIONS GROW WELL?
LITZMAN J. – INTRAVENOUS IMMUNOGLOBULIN TREATMENT INCREASES ACTIVATION OF GRANULOCYTES IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY DISORDERS (CVID)
LÓPEZ L. – CHRONIC GRANULOMATOUS DISEASE POST-STEM CELL TRANSPLANTATION: CASE REPORT
LUONG T. – SIX CASES WITH WISKOTT ALDRICH SYNDROME IN VIETNAMESE CHILDREN: CLINICAL MANIFESTATIONS AND TREATMENT OUTCOME
MA F. – ARE THERE SECRETS IN HOW TO ASSESS OPTIMUM SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) INFUSION-SITES ON YOUR PATIENT USING NOVEL TECHNIQUE WITH A MECHANICAL CONSTANT PRESSURE SYSTEM (MCPS)?
MA F. – DEFINING FLOW RATE TO REDUCE INITIAL LOCAL-SITE REACTIONS IN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) THERAPY
MA F. – SUBCUTANEOUS NEEDLE SETS (SNS) IMPACT PATIENTS UNDERGOING SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) TREATMENTS
MA F. – IMPROVING PATIENTS SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) TREATMENTS THROUGH RIGHT SELECTION OF INFUSION DEVICE TECHNOLOGY
MALLILLIN J. – A NEONATE WITH MULTIPLE SKIN ABSCESSES
MARIA S. – LATE ONSET COMMON VARIABLE IMMUNODEFICIENCY PRESENTING AS CYTOMEGALOVIRUS ASSOCIATED DEMYELINATION: A CASE REPORT
MARKELJ G. – THREE PATIENTS WITH A NOVEL WISKOTT-ALDRICH SYNDROM LIKE IMMUNODEFICIENCY CAUSED BY A ARPC1B MUTATION
MEESILPAVIKKAI K. – JAK1/2 INHIBITOR BARICITINIB AS A POTENTIAL THERAPY IN A PATIENT WITH GAIN-OF-FUNCTION MUTATION IN SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1)
MIDTTUN K. – HEALTH-RELATED QUALITY OF LIFE OF NORWEGIAN ADULTS WITH PRIMARY IMMUNODEFICIENCY
MILOTA T. – THE MECHANISMS OF IMMUNE SYSTEM DYSREGULATION IN COMMON VARIABLE IMMUNODEFICIENCY – THE ROLE OF T-HELPER CELLS
MOHAMMED ALI R. – PRIMARY IMMUNODEFICIENCY IN THE ADULT POPULATION; A GROWING PERCEPTION THAT NEEDS ATTENTION IN THE MIDDLE EAST.
MOKHANTAR K. – COMMON VARIABLE IMMUNODEFICIENCY : ABOUT 25 CASES
MUKTIARTI D. – IMMUNE DYSREGULATION, POLYENDOCRINOPATHY, ENTEROPATHY, X-LINKED (IPEX) SYNDROME: THE FIRST CASE REPORT FROM INDONESIA
MUNTEANU A. – EXTENDED LYMPHOCYTE IMMUNOPHENOTYPING FOR IMMUNODIAGNOSIS OF RECURRENT INFECTIONS OCCURRING IN THE ABSENCE OF PRIMARY IMMUNODEFICIENCY
NEKOOIE MARNANY N. – IRANIAN MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE (MSMD) REGISTRY AND BIOBANK IN ISFAHAN IMMUNODEFICIENCY RESEARCH CENTER (IIRC)
NG Y. – DIAGNOSTICS OF PRIMARY ANTIBODY DEFICIENCIES THROUGH TARGETED NEXT GENERATION SEQUENCING PANEL
NGUYEN L. – SHOULD PENICILLIOSIS BE CONSIDERED AS A SIGN OF PRIMARY IMMUNODEFICIENCY DISEASE: A CLINICAL CASE REPORT
NIKOLAIENKO T. – INFLUENCE EXOGENOUS EGF ON THE EXPRESSION VEGF BY TUMOR CELLS
NURIA BENGALA ZURRO N. – DIAGNOSIS OF PATIENTS WITH MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE (MSMD) USING LYSATE OF MYCOBACTERIA (LM) AND PURIFIED PROTEIN (PPD)
OUAJA R. – EFFICACY AND SAFETY OF A NOVEL 10% HUMAN INTRAVENOUS IMMUNOGLOBULIN (IQYMUNE®)
OUAZAHROU K. – AUTOIMMUNE DISEASES DURING PRIMARY IMMUNODEFICIENCIES
OZDEMIR O. – A PATIENT WITH RECURRENT HERPES INFECTION: CASE REPORT
PARIS K. – ADVERSE EVENTS AND TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN 20% IN PEDIATRIC PATIENTS (<18 YEARS OLD) WITH PRIMARY IMMUNODEFICIENCY DISEASES
PARKER A. – INDIVIDUALS WITH MODERATE IGG DEFICIENCY ARE SEROLOGICALLY DIFFERENT FROM THOSE WITH SEVERE IGG DEFICIENCY AND THOSE WITH NORMAL IGG.
PATEL S. – CURE FOR CHILDREN WITH SEVERE COMBINED IMMUNODEFICIENCY – NOW A REALITY IN INDIA!
PETERSHEIM D. – MECHANISMS OF GENOTYPE-PHENOTYPE CORRELATION IN AUTOSOMAL DOMINANT ANHIDROTIC ECTODERMAL DYSPLASIA WITH IMMUNE DEFICIENCY
PILANIA R. – LIVER ABSCESS IN CHRONIC GRANULOMATOUS DISEASE: A SINGLE CENTRE EXPERIENCE FROM A TERTIARY CARE CENTRE IN NORTH INDIA
PILANIA R. – INFECTIONS, AUTOIMMUNITY AND MALIGNANCIES IN WISKOTT ALDRICH SYNDROME: A SINGLE CENTRE EXPERIENCE FROM NORTH-WEST INDIA
PIRES C. – THE DIFFICULTY IN DIAGNOSING CHRONIC GRANULOMATOUS DISEASE IN BRAZIL
PONTES CUNHA DE CASTRO M. – CLINICAL AND GENETIC CHARACTERISTICS OF PATIENTS WITH WISKOTT-ALDRICH SYNDROME IN BRAZIL
PRAMANIK L. – CASE REPORT: SUCCESSFUL TREATMENT OF LEUKOCYTE ADHESION DEFICIENCY TYPE 1 SYNDROME AND RECURRENT PYODERMA GANGRENOSUM WITH ALLOGENEIC STEM CELL TRANSPLANTATION
PRANDZIOCH B. – HOW TO EDUCATE CHILDREN ABOUT PID? STUDY CASE FROM POLAND: EDUCATIONAL BOARD GAME
R R. – MONOCLONAL GAMMOPATHY IN A CHILD WITH WISKOTT – ALDRICH SYNDROME: A RARE OCCURRENCE
RAMAKERS J. – CINCA-SYNDROME PRESENTING AS HYPEREOSINOPHILIC SYNDROME
RAYZAN E. – A CASE OF AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS DISEASE CAUSED BY CYBA MUTATION WITH A HOMOZYGOUS SYMPTOM-FREE MOTHER
RICHTER A. – MANUAL PUSH SUBCUTANEOUS IMMUNOGLOBULIN ADMINISTRATION IN PATIENTS WITH PRIMARY AND SECONDARY IMMUNODEFICIENCIES AND AUTOMIMMUNE DISORDERS: A CASE SERIES OF 18 PATIENTS
ROZARIO H. – HEALTH-RELATED QUALITY OF LIFE AND HEALTH RESOURCE UTILIZATION IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE BEFORE AND AFTER TREATMENT WITH IGG REPLACEMENT
SABUR H. – HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVER COMBINED IMMUNDEFICIENCY OR OMENN SYNDROM DUE TO ARTEMIS DEFECT: A SINGLE CENTER EXPERIENCE
SAGHAFI S. – ABDOMINAL AORTIC COARCTATION IN A DEDICATOR OF CYTOKINESIS 8 PATIENT
SAHU S. – A CASE REPORT ON GAIN-OF-FUNCTION MUTATION IN STAT1 GENE WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS FROM INDIA
SAIDANI K. – OMENN SYNDROME: CLINICAL AND IMMUNOLOGICAL PROFILE OF ALGERIAN PATIENTS.
SAIKIA B – BITING HYPER-IGE SYNDROME: THE TOOTH STORY.
SARRAFZADEH S. – IMMUNOLOGICAL ASSESSMENT AND MOLECULAR STUDYANALYSIS OF 15 IRANIAN MSMD PATIENTS
SAVA F. – A NEW CASE OF POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE IIIC WITH PRIMARY ANTIBODY FAILURE
SEDFI S. – BRUTON’S DISEASE IN AN ALGERIAN MALE DUE TO A NOVEL FRAMESHIFT MUTATION
SELCUK A. – A RARE IMMUNODEFICIENCY : GOOD SYNDROME
SELMANOVIC V. – ASYMPTOMATIC GIARDIASIS IN X-LINKED AGAMAGLOBULINEMIA PATIENT WITH SEVERE LUNG DISEASE, CHRONIC GINGIVITIS AND SHORT STATURE
SHA A. – IDENTIFYING CHILDREN WITH PRIMARY IMMUNODEFICIENCY DISORDERS FOR DEVELOPING EFFECTIVE PREVENTION STRATEGIES : EVIDENCE FROM SOUTH INDIA
SHA A. – HEALTH RELATED QUALITY OF LIFE AMONG HIV AFFECTED INDIVIDUALS
SHABANI M. – A CASE OF DOCK8 DEFICIENCY WITH PURE CUTANEOUS MANIFESTATIONS
SHANDILYA J.K. – BONE INFECTION IN CHRONIC GRANULOMATOUS DISEASE: EXPERIENCE AT OUR CENTER, PGIMER, INDIA.
SHANDILYA J.K. – BONE INFECTION IN CHRONIC GRANULOMATOUS DISEASE: EXPERIENCE AT OUR CENTER, PGIMER, INDIA.
SHARMA A. – CRYPTOCOCCAL INFECTIONS IN CHILDREN ASSOCIATED WITH PRIMARY IMMUNODEFICIENCY DISEASES: EXPERIENCE FROM CHANDIGARH
SHARMA M. – SPECTRUM OF MUTATION IN XLA FROM INDIA
SHARMA M. – MYRIAD FACES OF CHRONIC GRANULOMATOUS DISEASE: ALL IN THE FAMILY
SHARMA M. – PRENATAL DIAGNOSIS AND CARRIER SCREENING FOR PRIMARY IMMUNODEFICIENCY DISEASES
SHARMA V. – IMMUNOLOGICAL ASPECTS OF FULMINANT TYPE 1 DIABETES
SHERKAT R. – THE KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DS2 COULD BE A PROTECTIVE FACTOR AGAINST HEPATITIS B VIRUS INFECTION
SIDDIQUE A. – MEASURING TREATMENT SATISFACTION IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES RECEIVING IMMUNOGLOBULIN INFUSIONS
SINHA S. – SKEWING OF SAG MEDIATED THERAPY FOR A PREDOMINANT TH1 DURING VISCERAL LEISHMANIASIS ON TRIGGERING CD2 EPITOPE
SIZYAKINA L.P. – THE ROLE OF INNATE IMMUNITY IN DIFFERENT VARIANTS OF THE CLINICAL COURSE OF PRIMARY A- AND HYPO-GAMMAGLOBULINEMIA
SOMER A. – FUNGAL PNEUMONIA IN A CHILD WITH CHRONIC GRANULOMATOUS DISEASE COMPLICATED WITH HEMOPHAGOCYTOSIS
SOMER A. – PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A CHILD WITH DOCK 8 DEFICIENCY
SOUALI M. – FREQUENT AUTOINFLAMMATORY DISEASES IN MOROCCO : FAMILIAL MEDITERRANEAN FEVER AND MEVALONATE KINASE DEFICIENCY :ABOUT 8 CASES
STEPANOVSKYY Y. – TREATMENT WITH IL-BLOCKERS OF CHILDREN WITH AUTOINFLAMMATORY DISEASES. FIRST UKRAINIAN EXPERIENCE
STRAY-PEDERSEN A. – SECOND-TIER NEXT GENERATION SEQUENCING IN NEWBORN SCREENING PROVIDES RAPID MOLECULAR DIAGNOSTICS OF SEVERE COMBINED IMMUNODEFICIENCY
SURATANNON N. – NEUROBLASTOMA AMPLIFIED SEQUENCE (NBAS) MUTATIONS; THE SPECTRUM OF DISEASE
SURI D. – PRIMARY IMMUNODEFICIENCY DISEASES WITH NEUTROPENIA: CLINICAL AND MOLECULAR PROFILE FROM A TERTIARY CARE CENTRE IN INDIA.
TAHA S. – GOOD SYNDROME, A DISEASE WITH VARIED PRESENTATIONS
TANTOU S. – DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES AT THE MAJOR GREEK CENTER DURING THE LAST SIX YEARS
TANTOU S. – A GAIN OF FUNCTION STAT3 MUTATION LEADING TO TUBERCULOSIS, AUTOIMMUNE AND LYMPHOPROLIFERATIVE MANIFESTATIONS.
THUC H. – IMMUNOGLOBULIN REPLACEMENT THERAPY FOR CHILDREN WITH PRIMARY IMMUNODEFICIENCY DISEASES IN VIETNAM
TOUGHZA J. – FIRST BONE MARROW ALLOGRAFT AT CHEIKH KHALIFA HOSPITAL IN CASABLANCA
V S V. – TREOSULFAN BASED CONDITIONING REGIMENS – REDUCED TOXICITY WITH EXCELLENT OUTCOMES IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCY
VAN DER ENT M. – HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY RECEIVING IMMUNOGLOBULIN REPLACEMENT THERAPY
VULTAGGIO A. – A PROSPECTIVE, OBSERVATIONAL STUDY ON BI-WEEKLY 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY: THE IBIS STUDY
WIDHANI A. – MYCOPHENOLATE MOFETIL FOR TREATMENT OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND AUTOSOMAL RECESSIVE HYPER-IGE SYNDROME, A CASE REPORT
YAZDANI R. – DIFFERENT CLASSIFICATION OF CVID PATIENTS USING B-CELL SUBSETS
YAZDANI R. – EVALUATION OF PI3K/AKT/FOXO PATHWAY IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY
YEL L. – ANALYSES OF EFFICACY AND TOLERABILITY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES TREATED BY DIFFERENT MODES OF ADMINISTRATION OF IMMUNOGLOBULIN THERAPY DURING THREE CONSECUTIVE STUDIES
YEL LEMAN – LONG-TERM SAFETY OF HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNE GLOBULIN 10% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES IN THE UNITED STATES: INTERIM RESULTS OF A POST-AUTHORIZATION SAFETY STUDY
ZAHID MUSTAFA M. – CIRCULATING AUTOANTIBODIES AGAINST TUMOR ASSOCIATED ANTIGENS AS DIAGNOSTIC MARKERS IN PATIENTS WITH PRIMARY LIVER CANCERS
ZAINAL ABIDIN M.A. – CHARTING THE BEST COURSE FOR A PATIENT WITH CHRONIC GRANULOMATOUS DISEASE WITH COMPLEX PERIANAL FISTULA

– For additional information regarding poster display kindly reach out to:

For any additional information please contact the Organising Secretariat:
AIM Group International – LISBON OFFICE
Avenida Conde de Valbom 6, 5th floor – 1050-068 Lisbon (Portugal)
Direct +351 213 24 50 62
ipic2017@aimgroup.eu